Trials / Recruiting
RecruitingNCT06642610
CGM Dynamic Index for Predicting Prediabetes in Cystic Fibrosis
CGM Dynamic Index (CDI) for Predicting Prediabetes in People With Cystic Fibrosis
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 70 (estimated)
- Sponsor
- Indiana University · Academic / Other
- Sex
- All
- Age
- 12 Years – 55 Years
- Healthy volunteers
- Not accepted
Summary
The primary objective of this pilot study is to develop a CGM-based model to predict the progression from prediabetes to diabetes in individuals with cystic fibrosis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | CGM Dynamic Index (CDI) | Participants will undergo one-time oral glucose tolerance test (OGTT) and a one-time use of a CGM device, which will be worn for up to 10 days. |
Timeline
- Start date
- 2025-06-15
- Primary completion
- 2026-06-30
- Completion
- 2026-06-30
- First posted
- 2024-10-15
- Last updated
- 2025-07-29
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT06642610. Inclusion in this directory is not an endorsement.